<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38374172</PMID><DateRevised><Year>2024</Year><Month>02</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2730-664X</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>19</Day></PubDate></JournalIssue><Title>Communications medicine</Title><ISOAbbreviation>Commun Med (Lond)</ISOAbbreviation></Journal><ArticleTitle>Carotid body dysregulation contributes to Long COVID symptoms.</ArticleTitle><Pagination><StartPage>20</StartPage><MedlinePgn>20</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">20</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s43856-024-00447-5</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The symptoms of long COVID, which include fatigue, breathlessness, dysregulated breathing, and exercise intolerance, have unknown mechanisms. These symptoms are also observed in heart failure and are partially driven by increased sensitivity of the carotid chemoreflex. As the carotid body has an abundance of ACE2 (the cell entry mechanism for SARS-CoV-2), we investigated whether carotid chemoreflex sensitivity was elevated in participants with long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Non-hositalised participants with long-COVID (n&#x2009;=&#x2009;14) and controls (n&#x2009;=&#x2009;14) completed hypoxic ventilatory response (HVR; the measure of carotid chemoreflex sensitivity) and cardiopulmonary exercise tests. Parametric and normally distributed data were compared using Student's unpaired t-tests or ANOVA. Nonparametric equivalents were used where relevant. Peason's correlation coefficient was used to examine relationships between variables.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">During cardiopulmonary exercise testing the V<sub>E</sub>/VCO<sub>2</sub> slope (a measure of breathing efficiency) was higher in the long COVID group (37.8&#x2009;&#xb1;&#x2009;4.4) compared to controls (27.7&#x2009;&#xb1;&#x2009;4.8, P&#x2009;=&#x2009;0.0003), indicating excessive hyperventilation. The HVR was increased in long COVID participants (-0.44&#x2009;&#xb1;&#x2009;0.23&#x2009;l/min/ SpO<sub>2</sub>%, R<sup>2</sup>&#x2009;=&#x2009;0.77&#x2009;&#xb1;&#x2009;0.20) compared to controls (-0.17&#x2009;&#xb1;&#x2009;0.13&#x2009;l/min/SpO<sub>2</sub>%, R<sup>2</sup>&#x2009;=&#x2009;0.54&#x2009;&#xb1;&#x2009;0.38, P&#x2009;=&#x2009;0.0007). The HVR correlated with the V<sub>E</sub>/VCO<sub>2</sub> slope (r&#x2009;=&#x2009;-0.53, P&#x2009;=&#x2009;0.0036), suggesting that excessive hyperventilation may be related to carotid body hypersensitivity.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The carotid chemoreflex is sensitised in long COVID and may explain dysregulated breathing and exercise intolerance in these participants. Tempering carotid body excitability may be a viable treatment option for long COVID patients.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>El-Medany</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiology, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bristol Heart Institute, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Adams</LastName><ForeName>Zoe H</ForeName><Initials>ZH</Initials><AffiliationInfo><Affiliation>School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Blythe</LastName><ForeName>Hazel C</ForeName><Initials>HC</Initials><Identifier Source="ORCID">0000-0002-7824-4019</Identifier><AffiliationInfo><Affiliation>School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hope</LastName><ForeName>Katrina A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Anaesthetics, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kendrick</LastName><ForeName>Adrian H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdala Sheikh</LastName><ForeName>Ana Paula</ForeName><Initials>AP</Initials><Identifier Source="ORCID">0000-0001-6051-2591</Identifier><AffiliationInfo><Affiliation>School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paton</LastName><ForeName>Julian F R</ForeName><Initials>JFR</Initials><AffiliationInfo><Affiliation>Manaaki Manawa, The Centre for Heart Research, University of Auckland, Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nightingale</LastName><ForeName>Angus K</ForeName><Initials>AK</Initials><Identifier Source="ORCID">0000-0001-9435-726X</Identifier><AffiliationInfo><Affiliation>School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Bristol Heart Institute, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hart</LastName><ForeName>Emma C</ForeName><Initials>EC</Initials><Identifier Source="ORCID">0000-0002-4534-9586</Identifier><AffiliationInfo><Affiliation>School of Physiology, Pharmacology and Neuroscience, University of Bristol, Bristol, UK. Emma.hart@bristol.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Commun Med (Lond)</MedlineTA><NlmUniqueID>9918250414506676</NlmUniqueID><ISSNLinking>2730-664X</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>Patients with long COVID suffer from breathlessness during exercise, leading to exercise intolerance. We know that SARS-CoV-2, the virus that causes COVID-19, can infect carotid bodies which is a small sensory organ that sends signals to the brain for regulating breathing and blood pressure. This is called the carotid chemoreflex. However, it is not clear if SARS-CoV-2 infection affects carotid chemoreflex. Here, we examine whether the normal functioning of carotid chemoreflex is disrupted in non-hospitalised patients with long COVID and if this is linked to excessive breathing during exercise. Our study shows that carotid chemoreflex is more sensitive in long COVID patients, who are otherwise healthy. The carotid bodies could be a good therapeutic target for treating breathlessness in patients with long COVID.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></OtherAbstract><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>20</Day><Hour>11</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>20</Day><Hour>11</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>19</Day><Hour>23</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38374172</ArticleId><ArticleId IdType="pmc">PMC10876702</ArticleId><ArticleId IdType="doi">10.1038/s43856-024-00447-5</ArticleId><ArticleId IdType="pii">10.1038/s43856-024-00447-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Venkatesan P. NICE guideline on long COVID. Lancet Respir. Med. 2021;9:129. doi: 10.1016/S2213-2600(21)00031-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId><ArticleId IdType="pmc">PMC7832375</ArticleId><ArticleId IdType="pubmed">33453162</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson, E. J. et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad I, et al. High prevalence of persistent symptoms and reduced health-related quality of life 6 months after COVID-19. Front Public Health. 2023;11:1104267. doi: 10.3389/fpubh.2023.1104267.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1104267</ArticleId><ArticleId IdType="pmc">PMC9932930</ArticleId><ArticleId IdType="pubmed">36817925</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg. Health Eur. 2021;6:100122. doi: 10.1016/j.lanepe.2021.100122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinicalMedicine. 2023;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Antonelli M, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect. Dis. 2022;22:43&#x2013;55. doi: 10.1016/S1473-3099(21)00460-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00460-6</ArticleId><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>(ONS), O.f.N.S. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 2 February 2023. (ONS website, statistical bulletin, 2023).</Citation></Reference><Reference><Citation>Whitaker, M. et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400:452&#x2013;461. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin. Microbiol. Infect. 2022;28:657&#x2013;666. doi: 10.1016/j.cmi.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Durstenfeld MS, et al. Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults: a systematic review and meta-analysis. JAMA Netw Open. 2022;5:e2236057. doi: 10.1001/jamanetworkopen.2022.36057.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.36057</ArticleId><ArticleId IdType="pmc">PMC9557896</ArticleId><ArticleId IdType="pubmed">36223120</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I, et al. Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest. 2022;161:54&#x2013;63. doi: 10.1016/j.chest.2021.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.08.010</ArticleId><ArticleId IdType="pmc">PMC8354807</ArticleId><ArticleId IdType="pubmed">34389297</ArticleId></ArticleIdList></Reference><Reference><Citation>van Voorthuizen EL, van Helvoort HAC, Peters JB, van den Heuvel MM, van den Borst B. Persistent exertional dyspnea and perceived exercise intolerance after mild COVID-19: a critical role for breathing dysregulation? Phys. Ther. 2022;102:pzac105. doi: 10.1093/ptj/pzac105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ptj/pzac105</ArticleId><ArticleId IdType="pmc">PMC9384552</ArticleId><ArticleId IdType="pubmed">35900016</ArticleId></ArticleIdList></Reference><Reference><Citation>Fr&#xe9;sard I, et al. Dysfunctional breathing diagnosed by cardiopulmonary exercise testing in &#x2018;long COVID&#x2019; patients with persistent dyspnoea. BMJ Open Respir. Res. 2022;9:e001126. doi: 10.1136/bmjresp-2021-001126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001126</ArticleId><ArticleId IdType="pmc">PMC8968537</ArticleId><ArticleId IdType="pubmed">35354589</ArticleId></ArticleIdList></Reference><Reference><Citation>Pijacka W, et al. Purinergic receptors in the carotid body as a new drug target for controlling hypertension. Nat. Med. 2016;22:1151&#x2013;1159. doi: 10.1038/nm.4173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4173</ArticleId><ArticleId IdType="pmc">PMC5750397</ArticleId><ArticleId IdType="pubmed">27595323</ArticleId></ArticleIdList></Reference><Reference><Citation>Iturriaga R, Alcayaga J, Chapleau MW, Somers VK. Carotid body chemoreceptors: physiology, pathology, and implications for health and disease. Physiol. Rev. 2021;101:1177&#x2013;1235. doi: 10.1152/physrev.00039.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00039.2019</ArticleId><ArticleId IdType="pmc">PMC8526340</ArticleId><ArticleId IdType="pubmed">33570461</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponikowski P, et al. Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure. Circulation. 2001;104:544&#x2013;549. doi: 10.1161/hc3101.093699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc3101.093699</ArticleId><ArticleId IdType="pubmed">11479251</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua TP, et al. Clinical characteristics of chronic heart failure patients with an augmented peripheral chemoreflex. Eur. Heart J. 1997;18:480&#x2013;486. doi: 10.1093/oxfordjournals.eurheartj.a015269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.eurheartj.a015269</ArticleId><ArticleId IdType="pubmed">9076386</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215&#x2013;220. doi: 10.1038/s41586-020-2180-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2180-5</ArticleId><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Villadiego J, et al. Is carotid body infection responsible for silent hypoxemia in COVID-19 patients? Function (Oxf) 2021;2:zqaa032. doi: 10.1093/function/zqaa032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/function/zqaa032</ArticleId><ArticleId IdType="pmc">PMC7717325</ArticleId><ArticleId IdType="pubmed">35321097</ArticleId></ArticleIdList></Reference><Reference><Citation>Villadiego J, et al. Is carotid body infection responsible for silent hypoxemia in COVID-19 Patients? Function. 2020;2:zqaa032. doi: 10.1093/function/zqaa032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/function/zqaa032</ArticleId><ArticleId IdType="pmc">PMC7717325</ArticleId><ArticleId IdType="pubmed">35321097</ArticleId></ArticleIdList></Reference><Reference><Citation>Porzionato A, et al. Case report: the carotid body in COVID-19: histopathological and virological analyses of an autopsy case series. Front Immunol. 2021;12:736529. doi: 10.3389/fimmu.2021.736529.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.736529</ArticleId><ArticleId IdType="pmc">PMC8576382</ArticleId><ArticleId IdType="pubmed">34764954</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambermont B, Davenne E, Maclot F, Delvenne P. SARS-CoV-2 in carotid body. Intensive Care Med. 2021;47:342&#x2013;343. doi: 10.1007/s00134-021-06351-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06351-z</ArticleId><ArticleId IdType="pmc">PMC7820831</ArticleId><ArticleId IdType="pubmed">33481041</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultz HD. Angiotensin and carotid body chemoreception in heart failure. Curr. Opin. Pharmacol. 2011;11:144&#x2013;149. doi: 10.1016/j.coph.2010.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coph.2010.12.004</ArticleId><ArticleId IdType="pmc">PMC3075378</ArticleId><ArticleId IdType="pubmed">21242106</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen AM. Angiotensin AT1 receptor-mediated excitation of rat carotid body chemoreceptor afferent activity. J. Physiol. 1998;510:773&#x2013;781. doi: 10.1111/j.1469-7793.1998.773bj.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-7793.1998.773bj.x</ArticleId><ArticleId IdType="pmc">PMC2231066</ArticleId><ArticleId IdType="pubmed">9660892</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YL, et al. Angiotensin II enhances carotid body chemoreflex control of sympathetic outflow in chronic heart failure rabbits. Cardiovasc. Res. 2006;71:129&#x2013;138. doi: 10.1016/j.cardiores.2006.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardiores.2006.03.017</ArticleId><ArticleId IdType="pubmed">16650840</ArticleId></ArticleIdList></Reference><Reference><Citation>Rysz S, et al. COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system. Nat. Commun. 2021;12:2417. doi: 10.1038/s41467-021-22713-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22713-z</ArticleId><ArticleId IdType="pmc">PMC8065208</ArticleId><ArticleId IdType="pubmed">33893295</ArticleId></ArticleIdList></Reference><Reference><Citation>Nayor M, et al. Clinical and hemodynamic associations and prognostic implications of ventilatory efficiency in patients with preserved left ventricular systolic function. Circ Heart Fail. 2020;13:e006729. doi: 10.1161/CIRCHEARTFAILURE.119.006729.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCHEARTFAILURE.119.006729</ArticleId><ArticleId IdType="pmc">PMC7224335</ArticleId><ArticleId IdType="pubmed">32362167</ArticleId></ArticleIdList></Reference><Reference><Citation>Arena R, et al. Development of a ventilatory classification system in patients with heart failure. Circulation. 2007;115:2410&#x2013;2417. doi: 10.1161/CIRCULATIONAHA.107.686576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.107.686576</ArticleId><ArticleId IdType="pubmed">17452607</ArticleId></ArticleIdList></Reference><Reference><Citation>Neder JA, et al. Exercise ventilatory inefficiency in mild to end-stage COPD. Eur. Respir. J. 2015;45:377&#x2013;387. doi: 10.1183/09031936.00135514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00135514</ArticleId><ArticleId IdType="pubmed">25359345</ArticleId></ArticleIdList></Reference><Reference><Citation>Excellence, N.I.f.H.a.C. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NG188 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams B, et al. 2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC) Blood Press. 2018;27:314&#x2013;340. doi: 10.1080/08037051.2018.1527177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08037051.2018.1527177</ArticleId><ArticleId IdType="pubmed">30380928</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters R, et al. Orthostatic hypotension and symptomatic subclinical orthostatic hypotension increase risk of cognitive impairment: an integrated evidence review and analysis of a large older adult hypertensive cohort. Eur. Heart J. 2018;39:3135&#x2013;3143. doi: 10.1093/eurheartj/ehy418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehy418</ArticleId><ArticleId IdType="pmc">PMC6122132</ArticleId><ArticleId IdType="pubmed">30052878</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BL, et al. Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement. Am J. Respir. Crit. Care Med. 2019;200:e70&#x2013;e88. doi: 10.1164/rccm.201908-1590ST.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201908-1590ST</ArticleId><ArticleId IdType="pmc">PMC6794117</ArticleId><ArticleId IdType="pubmed">31613151</ArticleId></ArticleIdList></Reference><Reference><Citation>Quanjer PH, et al. Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations. Eur. Respir. J. 2012;40:1324&#x2013;1343. doi: 10.1183/09031936.00080312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00080312</ArticleId><ArticleId IdType="pmc">PMC3786581</ArticleId><ArticleId IdType="pubmed">22743675</ArticleId></ArticleIdList></Reference><Reference><Citation>ATS/ACCP Statement on cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med.167, 211&#x2013;277. (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12524257</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua TP, Coats AJ. The reproducibility and comparability of tests of the peripheral chemoreflex: comparing the transient hypoxic ventilatory drive test and the single-breath carbon dioxide response test in healthy subjects. Eur. J. Clin. Invest. 1995;25:887&#x2013;892. doi: 10.1111/j.1365-2362.1995.tb01962.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2362.1995.tb01962.x</ArticleId><ArticleId IdType="pubmed">8719926</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat. Commun. 2022;13:446. doi: 10.1038/s41467-021-27797-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Sylvester KP, et al. ARTP statement on pulmonary function testing 2020. BMJ Open Respir. Res. 2020;7:e000575. doi: 10.1136/bmjresp-2020-000575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2020-000575</ArticleId><ArticleId IdType="pmc">PMC7337892</ArticleId><ArticleId IdType="pubmed">32631927</ArticleId></ArticleIdList></Reference><Reference><Citation>Morgan BJ, Adrian R, Bates ML, Dopp JM, Dempsey JA. Quantifying hypoxia-induced chemoreceptor sensitivity in the awake rodent. J. Appl. Physiol. 2014;117:816&#x2013;824. doi: 10.1152/japplphysiol.00484.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00484.2014</ArticleId><ArticleId IdType="pmc">PMC4187053</ArticleId><ArticleId IdType="pubmed">25080926</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley MS, Nicholls DP, Cooper CB. Cardiopulmonary exercise testing and metabolic myopathies. Ann. Am. Thorac. Soc. 2017;14:S129&#x2013;S139. doi: 10.1513/AnnalsATS.201701-014FR.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.201701-014FR</ArticleId><ArticleId IdType="pubmed">28590155</ArticleId></ArticleIdList></Reference><Reference><Citation>Glaab T, Taube C. Practical guide to cardiopulmonary exercise testing in adults. Respir. Res. 2022;23:9. doi: 10.1186/s12931-021-01895-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-021-01895-6</ArticleId><ArticleId IdType="pmc">PMC8754079</ArticleId><ArticleId IdType="pubmed">35022059</ArticleId></ArticleIdList></Reference><Reference><Citation>Balady GJ, et al. Clinician&#x2019;s Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010;122:191&#x2013;225. doi: 10.1161/CIR.0b013e3181e52e69.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIR.0b013e3181e52e69</ArticleId><ArticleId IdType="pubmed">20585013</ArticleId></ArticleIdList></Reference><Reference><Citation>Guyenet PG, Bayliss DA. Central respiratory chemoreception. Handb. Clin. Neurol. 2022;188:37&#x2013;72. doi: 10.1016/B978-0-323-91534-2.00007-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-323-91534-2.00007-2</ArticleId><ArticleId IdType="pmc">PMC10557475</ArticleId><ArticleId IdType="pubmed">35965033</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones NL, Robertson DG, Kane JW. Difference between end-tidal and arterial PCO2 in exercise. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 1979;47:954&#x2013;960.</Citation><ArticleIdList><ArticleId IdType="pubmed">511720</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones NL, Robertson DG, Kane JW. Difference between end-tidal and arterial PCO2 in exercise. J. Appl. Physiol. 1979;47:954&#x2013;960. doi: 10.1152/jappl.1979.47.5.954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1979.47.5.954</ArticleId><ArticleId IdType="pubmed">511720</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen JE, Ulubay G, Chow BF, Sun XG, Wasserman K. Mixed-expired and end-tidal CO2 distinguish between ventilation and perfusion defects during exercise testing in patients with lung and heart diseases. Chest. 2007;132:977&#x2013;983. doi: 10.1378/chest.07-0619.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.07-0619</ArticleId><ArticleId IdType="pubmed">17573506</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaudry RI, et al. Persistent dyspnea after COVID-19 is not related to cardiopulmonary impairment; a cross-sectional study of persistently dyspneic COVID-19, non-dyspneic COVID-19 and controls. Front. Physiol. 2022;13:917886. doi: 10.3389/fphys.2022.917886.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.917886</ArticleId><ArticleId IdType="pmc">PMC9297912</ArticleId><ArticleId IdType="pubmed">35874528</ArticleId></ArticleIdList></Reference><Reference><Citation>Younes, M. Measurement and testing of respiratory drive, (Dekker, 1981).</Citation></Reference><Reference><Citation>Blain GM, Smith CA, Henderson KS, Dempsey JA. Contribution of the carotid body chemoreceptors to eupneic ventilation in the intact, unanesthetized dog. J. Appl. Physiol. 2009;106:1564&#x2013;1573. doi: 10.1152/japplphysiol.91590.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.91590.2008</ArticleId><ArticleId IdType="pmc">PMC2681333</ArticleId><ArticleId IdType="pubmed">19246650</ArticleId></ArticleIdList></Reference><Reference><Citation>Stickland MK, Neder JA, Guenette JA, O&#x2019;Donnell DE, Jensen D. Using cardiopulmonary exercise testing to understand dyspnea and exercise intolerance in respiratory disease. Chest. 2022;161:1505&#x2013;1516. doi: 10.1016/j.chest.2022.01.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2022.01.021</ArticleId><ArticleId IdType="pubmed">35065052</ArticleId></ArticleIdList></Reference><Reference><Citation>Paton JF, et al. The carotid body as a therapeutic target for the treatment of sympathetically mediated diseases. Hypertension. 2013;61:5&#x2013;13. doi: 10.1161/HYPERTENSIONAHA.111.00064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.111.00064</ArticleId><ArticleId IdType="pubmed">23172927</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejours P. Chemoreflexes in breathing. Physiol. Rev. 1962;42:335&#x2013;358. doi: 10.1152/physrev.1962.42.3.335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.1962.42.3.335</ArticleId><ArticleId IdType="pubmed">13884932</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannoni A, et al. Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure. J. Am. Coll. Cardiol. 2009;53:1975&#x2013;1980. doi: 10.1016/j.jacc.2009.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2009.02.030</ArticleId><ArticleId IdType="pubmed">19460611</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith CA, Harms CA, Henderson KS, Dempsey JA. Ventilatory effects of specific carotid body hypocapnia and hypoxia in awake dogs. J. Appl. Physiol. 1997;82:791&#x2013;798. doi: 10.1152/jappl.1997.82.3.791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jappl.1997.82.3.791</ArticleId><ArticleId IdType="pubmed">9074965</ArticleId></ArticleIdList></Reference><Reference><Citation>Tipton MJ, Harper A, Paton JFR, Costello JT. The human ventilatory response to stress: rate or depth? J. Physiol. 2017;595:5729&#x2013;5752. doi: 10.1113/JP274596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP274596</ArticleId><ArticleId IdType="pmc">PMC5577533</ArticleId><ArticleId IdType="pubmed">28650070</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitt AK, et al. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation. 2002;106:3079&#x2013;3084. doi: 10.1161/01.CIR.0000041428.99427.06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.CIR.0000041428.99427.06</ArticleId><ArticleId IdType="pubmed">12473555</ArticleId></ArticleIdList></Reference><Reference><Citation>Gluck SL. Acid-base. Lancet. 1998;352:474&#x2013;479. doi: 10.1016/S0140-6736(98)03087-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(98)03087-6</ArticleId><ArticleId IdType="pubmed">9708770</ArticleId></ArticleIdList></Reference><Reference><Citation>Skatrud JB, Dempsey JA. Interaction of sleep state and chemical stimuli in sustaining rhythmic ventilation. J. Appl. Physiol. Respir. Environ. Exerc. Physiol. 1983;55:813&#x2013;822.</Citation><ArticleIdList><ArticleId IdType="pubmed">6415011</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie A, Skatrud JB, Puleo DS, Rahko PS, Dempsey JA. Apnea-hypopnea threshold for CO2 in patients with congestive heart failure. Am. J. Respir. Crit. Care Med. 2002;165:1245&#x2013;1250. doi: 10.1164/rccm.200110-022OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.200110-022OC</ArticleId><ArticleId IdType="pubmed">11991873</ArticleId></ArticleIdList></Reference><Reference><Citation>Taverne J, et al. High incidence of hyperventilation syndrome after COVID-19. J. Thorac. Dis. 2021;13:3918&#x2013;3922. doi: 10.21037/jtd-20-2753.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-20-2753</ArticleId><ArticleId IdType="pmc">PMC8264705</ArticleId><ArticleId IdType="pubmed">34277081</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y, Li YL, Schultz HD. Role of blood flow in carotid body chemoreflex function in heart failure. J. Physiol. 2011;589:245&#x2013;258. doi: 10.1113/jphysiol.2010.200584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2010.200584</ArticleId><ArticleId IdType="pmc">PMC3039273</ArticleId><ArticleId IdType="pubmed">21078591</ArticleId></ArticleIdList></Reference><Reference><Citation>Netland J, Meyerholz DK, Moore S, Cassell M, Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol. 2008;82:7264&#x2013;7275. doi: 10.1128/JVI.00737-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00737-08</ArticleId><ArticleId IdType="pmc">PMC2493326</ArticleId><ArticleId IdType="pubmed">18495771</ArticleId></ArticleIdList></Reference><Reference><Citation>Guntur VP, et al. Signatures of mitochondrial dysfunction and impaired fatty acid metabolism in plasma of patients with post-acute sequelae of COVID-19 (PASC) Metabolites. 2022;12:1026. doi: 10.3390/metabo12111026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12111026</ArticleId><ArticleId IdType="pmc">PMC9699059</ArticleId><ArticleId IdType="pubmed">36355108</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes AP, Turner PJ, Buckler KJ, Kumar P. Moderate inhibition of mitochondrial function augments carotid body hypoxic sensitivity. Pflugers Arch. 2016;468:143&#x2013;155. doi: 10.1007/s00424-015-1745-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00424-015-1745-x</ArticleId><ArticleId IdType="pubmed">26490460</ArticleId></ArticleIdList></Reference><Reference><Citation>Lataro RM, et al. P2X3 receptor antagonism attenuates the progression of heart failure. Nat. Commun. 2023;14:1725. doi: 10.1038/s41467-023-37077-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-37077-9</ArticleId><ArticleId IdType="pmc">PMC10050083</ArticleId><ArticleId IdType="pubmed">36977675</ArticleId></ArticleIdList></Reference><Reference><Citation>McGarvey LP, et al. Efficacy and safety of gefapixant, a P2X(3) receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials. Lancet. 2022;399:909&#x2013;923. doi: 10.1016/S0140-6736(21)02348-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02348-5</ArticleId><ArticleId IdType="pubmed">35248186</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>